GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.5196
-0.0201 (-3.72%)
Nov 6, 2025, 1:20 PM EST - Market open
GeoVax Labs Employees
GeoVax Labs had 17 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$361,356
Profits / Employee
-$1,459,150
Market Cap
15.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17 | 0 | - |
| Dec 31, 2023 | 17 | 3 | 21.43% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | 2 | 22.22% |
| Dec 31, 2020 | 9 | 2 | 28.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GOVX News
- 3 months ago - GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 11 months ago - GeoVax Receives Notice of Allowance For Cancer Vaccine Patent - GlobeNewsWire
- 1 year ago - GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference - GlobeNewsWire
- 1 year ago - GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 1 year ago - GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024 - GlobeNewsWire